Pancreatic cancer’s scar-forming cells: what they do and how we might guide them to help patients
Official title: Pancreatic cancer-associated fibroblasts: function, detection, and regulation
Funded at Research Inst of Fox Chase Can Ctr · NIH-11330370 · Data updated 2026-11-12
A cancer research grant is studying the scar-forming cells in pancreatic tumors to understand how they affect tumor growth and how we might steer them toward helping patients.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Research Inst of Fox Chase Can Ctr NIH-funded |
| Lab location | 1 site (Philadelphia, United States) |
| Project start | June 1, 2022 |
| Project end | May 31, 2027 |
| Funding year | 2026 |
| Award (this year) | $520,918 |
| NIH project number | 5R01CA269660-05 |
| Project ID | NIH-11330370 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates are pancreatic cancer patients whose tumors exhibit desmoplasia and CAF activity and who could participate in future translational or clinical studies.
✕Less likely to help
Early stages of the research or non-CAF-related interventions may not benefit individual patients directly.
What this research studies
Pancreatic cancer often creates a dense, fibrous environment that involves cancer-associated fibroblasts (CAFs). This project looks at how CAFs produce the surrounding matrix and inflammatory signals, and how these interactions can either help or hinder cancer progression. By mapping the signaling paths between CAFs and the extracellular matrix, researchers hope to find ways to shift desmoplasia toward anti-tumor effects. The work uses 3D cell culture models and animal studies to explore these cellular conversations and identify potential targets for therapy. The ultimate goal is to inform future treatments that can make the tumor environment less supportive of cancer.
Why it matters
Potential benefit: If successful, the research could reveal strategies to normalize the tumor scar tissue and boost the body’s ability to fight pancreatic cancer.
How similar studies have gone: Prior work has shown that targeting CAFs and desmoplasia can influence tumor behavior, suggesting potential for translation to therapies; this project builds on and extends these approaches.
Where this research is happening
-
Research Inst of Fox Chase Can Ctr
Philadelphia, United States Active
Researchers
- Principal investigator: Cukierman, Edna — Research Inst of Fox Chase Can Ctr
- Study coordinator: Cukierman, Edna
Related research
Other NIH-funded projects on the same topics.
-
Microbial Dysbiosis and Its Role in Pancreatic Cancer
A doctor-researcher team at Northwestern University is studying how gut bacteria influence pancreatic cancer and its response to immunotherapy to find new ways to help patients.
-
Targeting aberrant enhancer landscapes in pancreatic cancer
A patient-facing look at a project that aims to understand how pancreatic cancer changes its cell identity and what that means for treatment.
-
Exosome-based microRNA biomarkers for early, non-invasive detection of pancreatic cancer
A study to develop a blood test that uses tiny RNA signals in exosomes to detect pancreatic cancer early, aiming to help people at risk or with early disease.
-
Exosome-based microRNA biomarkers for early detection of pancreatic cancer
A patient-friendly look at a study using tiny blood-based RNA markers inside exosomes to catch pancreatic cancer early without invasive procedures.
-
Programmable implanted living materials to fight pancreatic cancer
A patient-facing program will explore a safe, implantable living material that delivers sequential immunotherapies directly to pancreatic tumors to help fight cancer.
-
Targeting how platelets and pancreatic cancer talk to each other
A study exploring whether blocking the interaction between platelets and pancreatic cancer cells could slow cancer growth and spread and help identify new biomarkers.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.